Shares of Lexaria Bioscience, a company that transforms the delivery of other companies’ drugs using its patented technology, fell more than 6% on Tuesday, October 15, after it announced a raise of around $5 million through a private placement. Details On Tuesday, Lexaria stock lost over 6% to close at…
Shares of Freedom Holding have gained about 600% since listing five years ago on the Nasdaq. In 2019, the company became the first broker from the CIS on this U.S. exchange. Indeed, the Nasdaq IPO gave the business a major boost, says CEO Timur Turlov. Details Freedom Holding stock has…
Shares of Sidus Space, a space services company, plummeted around 16% in trading on Tuesday, October 15, following the announcement of the company’s third stock offering this year. The latest is expected to nearly double the company’s outstanding shares. Details Sidus Space stock lost almost 16% on Tuesday, closing at…
Over the past 12 months, merger and acquisition activity has increased across various sectors, notes Jefferies U.S. small- and mid-cap strategist Steven DeSanctis. This bodes well for the small-cap segment, since most deals involve smaller companies and improve their efficiency and performance. Details The number of M&A deals has now…
On Monday, October 14, shares of Longboard Pharmaceuticals, which is developing medicines for neurological diseases, surged more than 50% after the company announced a deal to be acquired by its Danish peer Lundbeck. The transaction is valued at $2.6 billion, almost 14% above Longboard’s current market capitalization. Details On Monday,…
Small-cap stocks — companies with a market capitalization of between $250 million and $2 billion — can be a valuable addition to many portfolios, as they sometimes produce outsized returns, points out the Motley Fool in an article highlighting three smaller companies worth investing $1,000 in right now. Innodata Innodata,…
The dominance of the so-called “Magnificent Seven” stocks — the major tech companies that fueled the equity market’s growth in 2023-2024 — appears to be coming to an end. The main reason, according to Mark Sherlock, who runs a U.S. small- and mid-cap fund at Federated Hermes in London, is…
Quotes on Universal Insurance Holdings, Florida’s largest private insurer, closed nearly 12% higher on Thursday, October 10, as Hurricane Milton, which hit the state’s Gulf of Mexico coast on Wednesday-Thursday, turned out to be less destructive than anticipated. Experts had estimated that the hurricane could cause up to $10 billion…
The game of golf is growing at an impressive pace in the U.S.. In 2023, more than a third of Americans over the age of five either played golf, followed the game, or listened to a golf-related podcast — a 30% increase versus 2016, according to the National Golf Foundation…
At the start of trading today, Thursday, October 10, shares of fintech company IDT Corporation, a provider of communications and payment services, climbed nearly 4% to hit their highest level in almost three years. This followed a 21% gain the previous day. The surge is attributable to announced financial results…
Citi has initiated coverage on truckload carrier Werner Enterprises, rating it a “sell” with a target price about 7% below the current market price. This was part of a broader initiation on 19 transportation and logistics companies, with Werner receiving the only sell recommendation. Details On Wednesday, October 9, Citi…
Micro-cap real estate investor, developer, and manager Caliber has reached an agreement with the investment management firm Satori Collective in which Satori will contribute seven hotels to Caliber. The hotels, located in the Midwestern and Southern U.S., operate under global brands such as Marriott, Hilton, and IHG. The deal will…
For high returns, investors should look for small-cap investments with the potential to grow into the mid-cap or even large-cap segment. Georgiy Timoshin, a financial analyst at Freedom Finance Global, highlights two undervalued companies that he believes could do just that. e.l.f. Beauty Cosmetic brand e.l.f. Beauty currently has a…
On Monday, October 7, shares of the biotech company Scholar Rock soared close to 362% following the announcement that its lead candidate, apitegromab, a treatment for spinal muscular atrophy (SMA), had demonstrated clinically significant results in the final, phase III trial. Currently, there are only three approved drugs for this…
Shares of fintech company DeFi Technologies rose around 6.0% on the Cboe Canada stock exchange and about 3.5% in over-the-counter trading in New York on Monday, October 7. The gains followed the announcement that the company had completed the acquisition of Stillman Digital, a leading digital asset liquidity provider. Zacks…
Now may be the right time to invest in small-cap stocks, says Antony Creighton, director and head of strategy for Asia ex-Japan at Lazard Asset Management, which oversees more than $205.2 billion in assets. The segment has likely hit bottom in terms of relative valuation, but with the Fed easing…
The fair value of Soligenix, a micro-cap pharmaceutical company, is estimated to be 800% higher than the current share price, according to a recent report by Zacks Small-Cap Research (Zacks SCR). Soligenix is developing several products, chief among which is a vaccine for the deadly, hemorrhagic-fever-causing Marburg virus. It is…
Quotes on EVgo, a small U.S. company that builds charging stations for electric vehicles (EVs), jumped more than 60% on Thursday, October 3. Earlier in the day, the U.S. Department of Energy (DOE) announced a conditional $1.05 billion loan guarantee for the company. The financing should allow EVgo to almost…
Quotes on Crescent Energy jumped 11% on Wednesday, October 2. At the end of the week, the name is set to be added to the S&P SmallCap 600 index, with index inclusion almost always bringing new long-term investors, according to a Nasdaq study. Details On Wednesday, Crescent Energy stock gained…
Small caps turned out to be some of the most profitable investments in the third quarter of 2024. The iShares Russell 2000 ETF (which tracks the performance of the Russell 2000 index) reported an 8.87% return versus 5.43% for the large-cap S&P 500, points out Georgiy Timoshin, a financial analyst…
Acurx Pharmaceuticals has released promising trial results for its lead drug candidate, ibezapolstat, an antibiotic for difficult-to-treat bacterial infections. It was found to effectively target Gram-positive bacteria without causing cross resistance with other antibiotics — in other words, ibezapolstat may work where other antibiotics fail. Even though Acurx stock has…
Shares of Lexaria Bioscience, a company using its patented technology to change the delivery of drugs made by other firms, rose more than 3% on Tuesday, October 1, following the announcement of a new CFO. This comes on the heels of a CEO change, which signaled a strategic shift as…
The U.S. SEC has initiated and settled legal proceedings against Howard Jonas, the founder of communications and payments fintech company IDT Corporation. Jonas is said to have failed to promptly disclose his stock holdings in four companies, including IDT. Details On September 25, the SEC filed an administrative case against…
Wells Fargo analysts believe that the tight U.S. presidential race, combined with favorable economic conditions, presents an attractive opportunity for a near-term small-cap trade. They expect a 5-10% outperformance by small caps versus the market if Trump wins. Details Small caps could outperform the main U.S. market index, the S&P…
